• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生存策略:肿瘤缺氧微环境如何调控血管生成。

Survival strategies: How tumor hypoxia microenvironment orchestrates angiogenesis.

机构信息

College of Traditional Chinese Medicine, Shandong Second Medical University, Weifang 261053, China.

First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250014, China.

出版信息

Biomed Pharmacother. 2024 Jul;176:116783. doi: 10.1016/j.biopha.2024.116783. Epub 2024 May 25.

DOI:10.1016/j.biopha.2024.116783
PMID:38796970
Abstract

During tumor development, the tumor itself must continuously generate new blood vessels to meet their growth needs while also allowing for tumor invasion and metastasis. One of the most common features of tumors is hypoxia, which drives the process of tumor angiogenesis by regulating the tumor microenvironment, thus adversely affecting the prognosis of patients. In addition, to overcome unsuitable environments for growth, such as hypoxia, nutrient deficiency, hyperacidity, and immunosuppression, the tumor microenvironment (TME) coordinates angiogenesis in several ways to restore the supply of oxygen and nutrients and to remove metabolic wastes. A growing body of research suggests that tumor angiogenesis and hypoxia interact through a complex interplay of crosstalk, which is inextricably linked to the TME. Here, we review the TME's positive contribution to angiogenesis from an angiogenesis-centric perspective while considering the objective impact of hypoxic phenotypes and the status and limitations of current angiogenic therapies.

摘要

在肿瘤发展过程中,肿瘤本身必须不断产生新的血管以满足其生长需求,同时也允许肿瘤侵袭和转移。肿瘤最常见的特征之一是缺氧,它通过调节肿瘤微环境来驱动肿瘤血管生成过程,从而对患者的预后产生不利影响。此外,为了克服生长不适宜的环境,如缺氧、营养缺乏、酸中毒和免疫抑制,肿瘤微环境(TME)通过多种方式协调血管生成,以恢复氧气和营养物质的供应,并清除代谢废物。越来越多的研究表明,肿瘤血管生成和缺氧通过复杂的相互作用相互作用,这与 TME 密不可分。在这里,我们从血管生成为中心的角度回顾 TME 对血管生成的积极贡献,同时考虑缺氧表型的客观影响以及当前血管生成治疗的现状和局限性。

相似文献

1
Survival strategies: How tumor hypoxia microenvironment orchestrates angiogenesis.生存策略:肿瘤缺氧微环境如何调控血管生成。
Biomed Pharmacother. 2024 Jul;176:116783. doi: 10.1016/j.biopha.2024.116783. Epub 2024 May 25.
2
Havoc in harmony: Unravelling the intricacies of angiogenesis orchestrated by the tumor microenvironment.扰乱和谐:揭示肿瘤微环境调控的血管生成复杂性。
Cancer Treat Rev. 2024 Jun;127:102749. doi: 10.1016/j.ctrv.2024.102749. Epub 2024 May 1.
3
The Sabotaging Role of Myeloid Cells in Anti-Angiogenic Therapy: Coordination of Angiogenesis and Immune Suppression by Hypoxia.髓系细胞在抗血管生成治疗中的破坏作用:缺氧对血管生成与免疫抑制的协调作用
J Cell Physiol. 2017 Sep;232(9):2312-2322. doi: 10.1002/jcp.25726. Epub 2017 Apr 10.
4
Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.缺氧肿瘤微环境中的血管生成拟态机制。
Mol Cancer. 2021 Jan 4;20(1):7. doi: 10.1186/s12943-020-01288-1.
5
Anti-Angiogenic Therapy: Current Challenges and Future Perspectives.抗血管生成疗法:当前挑战与未来展望
Int J Mol Sci. 2021 Apr 5;22(7):3765. doi: 10.3390/ijms22073765.
6
Role of anti-angiogenic factors in the pathogenesis of breast cancer: A review of therapeutic potential.抗血管生成因子在乳腺癌发病机制中的作用:治疗潜力综述。
Pathol Res Pract. 2022 Aug;236:153956. doi: 10.1016/j.prp.2022.153956. Epub 2022 May 27.
7
Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies.肿瘤缺氧调控免疫逃逸/浸润:对血管生成的影响及缺氧生物标志物对癌症治疗的潜在影响。
Front Immunol. 2021 Jan 20;11:613114. doi: 10.3389/fimmu.2020.613114. eCollection 2020.
8
Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.针对肿瘤微环境设计和开发新型抗血管生成药物以抑制肿瘤生长。
Prog Biophys Mol Biol. 2013 Nov;113(2):333-54. doi: 10.1016/j.pbiomolbio.2013.10.001. Epub 2013 Oct 15.
9
Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.丹参酮IIA通过在人结直肠癌的常氧微环境中靶向转化生长因子-β1(TGF-β1)以及在低氧微环境中靶向缺氧诱导因子-1α(HIF-1α)来抑制β-连环蛋白/血管内皮生长因子(VEGF)介导的血管生成。
Cancer Lett. 2017 Sep 10;403:86-97. doi: 10.1016/j.canlet.2017.05.013. Epub 2017 Jun 7.
10
Targeting hypoxic tumor microenvironment in pancreatic cancer.针对胰腺癌的缺氧肿瘤微环境。
J Hematol Oncol. 2021 Jan 13;14(1):14. doi: 10.1186/s13045-020-01030-w.

引用本文的文献

1
Hypoxia promotes pancreatic adenocarcinoma progression by stabilizing ID1 via TRIM21 suppression.缺氧通过抑制TRIM21使ID1稳定,从而促进胰腺腺癌进展。
Front Oncol. 2025 Aug 21;15:1616968. doi: 10.3389/fonc.2025.1616968. eCollection 2025.
2
Gold/Prussian Blue-Based Nanocomposites with Dual Nanozyme Activities Exert a Synergistic Effect of Starvation Therapy and Sonodynamic Therapy in the Treatment of Liver Cancer.具有双纳米酶活性的金/普鲁士蓝基纳米复合材料在肝癌治疗中发挥饥饿疗法和超声动力学疗法的协同作用。
Int J Nanomedicine. 2025 Sep 1;20:10721-10737. doi: 10.2147/IJN.S490343. eCollection 2025.
3
Tackling tumor hypoxia: advances in breaking the oncogenic HIF-1α-p300/CBP alliance.
应对肿瘤缺氧:打破致癌性HIF-1α-p300/CBP联盟的进展
Invest New Drugs. 2025 Aug 21. doi: 10.1007/s10637-025-01570-3.
4
Cancer-Associated Fibroblasts: Immunosuppressive Crosstalk with Tumor-Infiltrating Immune Cells and Implications for Therapeutic Resistance.癌症相关成纤维细胞:与肿瘤浸润免疫细胞的免疫抑制性串扰及其对治疗耐药性的影响
Cancers (Basel). 2025 Jul 28;17(15):2484. doi: 10.3390/cancers17152484.
5
Hypoxic cancer-associated fibroblast exosomal circSTAT3 drives triple negative breast cancer stemness via miR-671-5p/NOTCH1 signaling.缺氧的癌症相关成纤维细胞外泌体环状STAT3通过miR-671-5p/NOTCH1信号传导驱动三阴性乳腺癌干性。
J Transl Med. 2025 Jul 23;23(1):814. doi: 10.1186/s12967-025-06794-8.
6
Nanostrategies synergize with locoregional interventional therapies for boosting antitumor immunity.纳米策略与局部区域介入治疗协同作用以增强抗肿瘤免疫力。
Bioact Mater. 2025 May 31;51:634-649. doi: 10.1016/j.bioactmat.2025.05.016. eCollection 2025 Sep.
7
Tumor-infiltrating immune cells state-implications for various breast cancer subtypes.肿瘤浸润免疫细胞状态对不同乳腺癌亚型的影响
Front Immunol. 2025 May 14;16:1550003. doi: 10.3389/fimmu.2025.1550003. eCollection 2025.
8
Extracellular matrix: unlocking new avenues in cancer treatment.细胞外基质:开启癌症治疗新途径
Biomark Res. 2025 May 27;13(1):78. doi: 10.1186/s40364-025-00757-3.
9
CircPRKCA facilitates esophageal squamous cell carcinoma metastasis via m5C-dependent CSF2 mRNA stabilization.环状PRKCA通过m5C依赖的CSF2 mRNA稳定性促进食管鳞状细胞癌转移。
J Transl Med. 2025 Apr 1;23(1):385. doi: 10.1186/s12967-025-06395-5.
10
Tumor‑associated neutrophils: Critical regulators in cancer progression and therapeutic resistance (Review).肿瘤相关中性粒细胞:癌症进展和治疗耐药性的关键调节因子(综述)
Int J Oncol. 2025 Apr;66(4). doi: 10.3892/ijo.2025.5734. Epub 2025 Feb 28.